Liu Ping, Chief Physician and Master's Supervisor at the Reproductive Medicine Center of Peking University Third Hospital. With nearly 40 years of experience in reproductive medicine, she served as a key developer, pioneer, and founder of groundbreaking technologies including mainland China's first IVF baby and first frozen-thawed embryo IVF. She has made outstanding contributions to the establishment, development, safe implementation, and quality control of assisted reproductive technologies in China. Completed the National Key RESEARCH AND DEVELOPMENT Program project “Establishment of a Standardized System for the Prevention and Treatment of Reproductive Diseases” as the principal investigator. The project conducted a nationwide cross-sectional survey on reproductive health among women of childbearing age across 15 provinces/municipalities, completing 13,508 questionnaires along with physical examinations and gynecological ultrasounds. Blood samples were collected from 10,710 participants to establish a biobank. Through hormonal measurements, the study determined the distribution of AMH levels across different age groups among reproductive-age women in mainland China, establishing 'normal' reference ranges and documenting variations in thyroid-related hormone levels. Epidemiological questionnaire results revealed key data during the 13th Five-Year Plan period (including basic reproductive health indicators, common reproductive disorders, infertility rates, and fertility intentions among women of childbearing age) against the backdrop of China's evolving population growth and demographic structure. This survey continued the investigation on polycystic ovary syndrome (PCOS) initiated during the 11th Five-Year Plan period. It concluded that PCOS incidence has risen over the past decade and identified changes in disease characteristics, providing evidence for the formulation and adjustment of national health policies. Served as Vice Chairperson of the Reproductive Medicine Branch of the Chinese Medical Association, Deputy Leader of the Laboratory Working Group, and Member of the Clinical Working Group. Recipient of numerous scientific awards, including:

- Two Second Prizes of the National Science and Technology Progress Award

- One First Prize of the Beijing Science and Technology Progress Award

- One Second Prize of the National Natural Science Award

- One Third Prize of the Ministry of Health Science and Technology Progress Award

- One First Prize of the Ministry of Education Science and Technology Progress Award

Authored over 20 research papers, contributed to 4 academic monographs, and served as chief editor for 1 publication.

2019: Vice Chairperson, Reproductive Medicine Branch, Chinese Medical Association

2011: Deputy Leader, Laboratory Working Group, Reproductive Medicine Branch, Chinese Medical Association

Vice Chair, Reproductive Endocrinology Committee, Chinese Maternal and Child Health Association

Vice Chair, Reproductive Medicine and Reproductive Ethics Branch, Chinese Association of Eugenics

2011: Vice Chair, Reproductive Medicine Branch, Beijing Medical Association

2015: Vice Chair, First Reproductive Endocrinology Committee, Beijing Association of Integrative Medicine

2016 Member, First Clinical Reproductive Genetics Committee, Medical Genetics Physicians Branch, Chinese Medical Doctor Association

(1) 2019 Second Prize, Ministry of Education Award for Scientific and Technological Progress in Higher Education Institutions, Research on Strategies to Enhance Safety and Efficacy of Assisted Reproductive Technologies (Ranked 2nd)

(2) 2015 First Prize, Beijing Science and Technology Award

(3) 2014: First Prize, Ministry of Education Award for Scientific and Technological Progress, Clinical Research on Diagnosis and Treatment of Refractory Infertility (Ranked 2nd)

(4) 2011: Second Prize, National Science and Technology Progress Award

(5) 2009: Second Prize, National Science and Technology Progress Award

(6) 2008: First Prize, Ministry of Education Award for Scientific and Technological Progress

(7) 2002: Nominated for the National Natural Science Award by the Ministry of Education

(8) 1999: Award for Integrating Basic Research with Clinical Practice, Beijing Medical University

(9) 1996: Award for Research and Application of Human Frozen-Thawed Embryo Transfer and Egg Donation In Vitro Fertilization-Embryo Transfer

(10) 1989: First Prize, Beijing Science and Technology Progress Award

(1) Zhuang XJ, Huang J, Li M, Wang YP, Qiu X, Zhu WW, Liu QL, Zhu JY, Lian Y, Liu P*, Qiao Jie*. Role of tripartite motif protein 27 as a gametogenesis-related protein in human germ cells. Int J Clin Exp Pathol. 2017;10(9):9427-9435.

(2)Li M, Lin S, Chen Y, Zhu J, Liu P*, Qiao J. Value of transferring embryos that show no evidence of fertilization at the time of fertilization assessment. Fertil Steril. 2015 104(3): 607-11.

(3)Zhu J, Zhuang X, Chen L, Liu P*, Qiao J*. Effect of embryo culture media on percentage of males at birth. Hum Reprod. 2015 30(5): 1039-45.

(4)Huang Jin, Liu Ping*, Chen Yongjian, Lian Ying, Zhang Qiufang. Experimental study on PCR technology for single-cell genetic diagnosis of cleavage-stage embryos. Chinese Journal of Eugenics and Genetics, 2007, 15(2): 32-33.

(5) Huang Jin, Liu Ping*, Chen Yongjian, Zhang Hong, Zheng Danxia, Zhang Xiaowei, Qiao Jie. Application of Fluorescent PCR Technology for Genetic Diagnosis of Polycystic Kidney Disease in Single Individual Cells. 2007, 29(2):283-286.

(6) Huang Jin, Lian Ying, Liu Ping*, Qiao Jie, Gao Xuefeng. Pregnancy and Delivery Following Preimplantation Genetic Diagnosis of a Frozen-Thawed Embryo. Chinese Journal of Obstetrics and Gynecology, 2009, 44(7):558.

(1) Invention Patent: A Method and Apparatus for Rapid Identification of Vitrification Solutions for Reproductive Cryopreservation, Patent No. ZL 2018103465348.